Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07686094
PHASE1
Placental Cells for Diabetic Foot Ulcers
Sponsor: Wake Forest University Health Sciences
View on ClinicalTrials.gov
Summary
The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.
Official title: Phase 1 Safety Trial of Placental Stem Cells (PLSC) to Accelerate the Healing of Diabetic Foot Ulcers
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2026-10
Completion Date
2028-12
Last Updated
2026-07-07
Healthy Volunteers
No
Conditions
Interventions
DRUG
Placenta Stem Cells
Injection of 30 M placenta stem cells into/around the diabetic foot ulcer and along the anterior and posterior tibial arteries of the index leg.
Locations (1)
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, United States